Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 6 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
The Koninklijke Nederlandse Akademie Van Wetenschappen is managing 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 6 distinct examiners and 6 distinct art units. The number of 6 distinct art units relative to the 7 pending office actions suggests a broad technical range for the academy's current research filings.
SCHUBERG, LAURA J is the busiest examiner, responsible for 2 busiest examiner pending office actions. This examiner handles a larger portion of the workload compared to the other 6 distinct examiners involved. With 7 pending office actions spread across 6 distinct art units, the academy's prosecution strategy involves interaction across multiple specialized divisions of the patent office.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (43%) |
| §112 only | 2 (29%) |
| Double-patenting only | 1 (14%) |
| Double-patenting + other | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHUBERG, LAURA J | 2 | 23.6% | +37.0% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 47.2% | +63.6% |
| TINSLEY, BRENDAN THOMAS | 1 | 60.4% | +74.3% |
| LANDAU, SHARMILA GOLLAMUDI | 1 | 11.1% | +4.6% |
| LAFAVE, ELIZABETH ROSE | 1 | 64.4% | +43.2% |
| GOUGH, TIFFANY MAUREEN | 1 | 31.7% | +46.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15654243 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | 146d overdue |
| 17410126 | Culture Medium | LANDAU, SHARMILA GOLLAMUDI | — |
| 16113445 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15654243 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | 146d overdue |
| 17284853 | Single cell full length RNA sequencing | LAFAVE, ELIZABETH ROSE | 49d overdue |
| 18264587 | Curing disease by transcription regulatory gene editing | LIPPOLIS, ALEXANDRA ROSE | — |
| 17611561 | IMPROVED CULTURE METHOD USING INTEGRIN AGONIST | TINSLEY, BRENDAN THOMAS | — |
| 17059965 | MATURE AIRWAY ORGANOIDS, METHODS OF MAKING AND USES THEREOF | GOUGH, TIFFANY MAUREEN | — |
| 16113445 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 1637 | 1 |
| 1634 | 1 |
| 1653 | 1 |
| 1684 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18264587 | Curing disease by transcription regulatory gene editing | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Final Rejection | — | Pending | Aug 08, 2023 |
| 17611561 | IMPROVED CULTURE METHOD USING INTEGRIN AGONIST | TINSLEY, BRENDAN THOMAS | 1634 | §112 | Non-Final OA | — | Pending | Nov 15, 2021 |
| 17410126 | Culture Medium | LANDAU, SHARMILA GOLLAMUDI | 1653 | §103 | Final Rejection | — | Pending | Aug 24, 2021 |
| 17284853 | Single cell full length RNA sequencing | LAFAVE, ELIZABETH ROSE | 1684 | §103Other | Non-Final OA | 49d overdue | Pending | Apr 13, 2021 |
| 17059965 | MATURE AIRWAY ORGANOIDS, METHODS OF MAKING AND USES THEREOF | GOUGH, TIFFANY MAUREEN | 1651 | §112 | Final Rejection | — | Pending | Nov 30, 2020 |
| 16113445 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | 1631 | §103§112DP | Final Rejection | — | Pending | Aug 27, 2018 |
| 15654243 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | 1631 | DP | Non-Final OA | 146d overdue | Pending | Jul 19, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKoninklijke Nederlandse Akademie Van Wetenschappen has 7 pending office actions as of October 2026, spread across 6 art units and 6 examiners.
Laura J Schuberg has the most, with 2 of Koninklijke Nederlandse Akademie Van Wetenschappen's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
